ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $853 | -92.7% | 1,047 | -91.8% | 0.00% | – |
| Q2 2023 | $11,740 | +1173900.0% | 12,719 | +1297.7% | 0.00% | – |
| Q1 2023 | $1 | -66.7% | 910 | -21.3% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 1,157 | -81.0% | 0.00% | – |
| Q3 2022 | $8,000 | +166.7% | 6,092 | +147.4% | 0.00% | – |
| Q2 2022 | $3,000 | +50.0% | 2,462 | +208.5% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 798 | -35.3% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 1,233 | -41.3% | 0.00% | – |
| Q2 2021 | $6,000 | +500.0% | 2,102 | +696.2% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 264 | -70.7% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 900 | -26.6% | 0.00% | – |
| Q1 2020 | $2,000 | -50.0% | 1,226 | +15.1% | 0.00% | – |
| Q4 2019 | $4,000 | -50.0% | 1,065 | -51.6% | 0.00% | -100.0% |
| Q2 2019 | $8,000 | +60.0% | 2,202 | +727.8% | 0.00% | – |
| Q4 2018 | $5,000 | -83.3% | 266 | -72.6% | 0.00% | -100.0% |
| Q3 2018 | $30,000 | – | 970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 250,518 | $722,000 | 0.59% |
| Nantahala Capital Management | 990,655 | $2,853,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 82,421 | $237,000 | 0.04% |
| FEDERATED HERMES, INC. | 117,673 | $339,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 179 | $516,000 | 0.00% |
| Horan Securities, Inc. | 24 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 200 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 29 | $0 | 0.00% |
| NORTHERN TRUST CORP | 31,083 | $90,000 | 0.00% |